Industry Wants Real-World Data to Serve as Grounds for Drug Pricing: JPMA Head

JPMA President Yoshihiko Hatanaka The pharmaceutical industry hopes to see real-world data serving as credible grounds to support the price-setting of innovative drugs, Yoshihiko Hatanaka, president of the Japan Pharmaceutical Manufacturers Association (JPMA), said. Speaking about the use of real-world...read more